Earningsreport

Q1/2025 12/31/2024 EPS -1.300 ZacksConsensus -1.250 ActVsEst (0.050) - Miss

Citius Pharmaceuticals, Inc.  (CTXR) 
NASDAQ:AMEX Investor Relations: ir.citiuspharma.com